We are live on ! Find out more
TNON icon

Tenon Medical

10 hedge funds and large institutions have $163K invested in Tenon Medical in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

234% more capital invested

Capital invested by funds: $48.6K → $163K (+$114K)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

67% more funds holding

Funds holding: 6 → 10 (+4)

13.19% more ownership

Funds ownership: 2.02% → 15.21% (+13%)

Holders
10
Holders Change
+4
Holders Change %
+66.67%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TNON Hedge Fund Activity: Q4 2024 in Review

10 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Tenon Medical (TNON) for Q4 2024, worth a combined $163K — up 234% from $48.6K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TNON positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $79.1K. The largest seller was Clear Street, exiting entirely with an estimated $1.11K sold.

  • 10 institutional investors held Tenon Medical (TNON) as of Q4 2024, up from 6 in Q3 2024.
  • Funds reported $163K of Tenon Medical stock for Q4 2024, up 234% quarter-over-quarter.
  • 5 funds opened new Tenon Medical positions in Q4 2024 and 1 closed out, a net change of +4 holders.
  • The largest Tenon Medical buyer in Q4 2024 was Renaissance Technologies, an estimated $79.1K added.
  • The largest Tenon Medical seller in Q4 2024 was Clear Street, an estimated $1.11K sold.

Based on aggregated 13F filings for Q4 2024.